P3 Health Partners- Warrants (19/11/2026) Return on Equity

P3 Health Partners- Warrants (19/11/2026) posts a ROE of 192.65%. That is above the sector sector average of -4.47%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -4.47% is typical. P3 Health Partners- Warrants (19/11/2026)'s 192.65% is higher that level. That is roughly 4411.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

P3 Health Partners- Warrants (19/11/2026)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 192.65%; use YoY and peer views to separate noise from signal.

Context for PIIIW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -4.47%), and (3) consistency with growth and profitability. This page covers the first two; P3 Health Partners- Warrants (19/11/2026)'s other metric pages and overview cover the third.